Core Viewpoint - Cannabis stocks experienced a significant surge, with Tilray Brands rising over 32%, Canopy Growth increasing over 23%, SNDL up over 19%, Aurora Cannabis rising over 11%, and Cronos Group gaining over 5% due to reports that President Donald Trump is considering reclassifying cannabis to a lower risk category [1] Group 1 - Tilray Brands (TLRY.US) saw an increase of over 32% [1] - Canopy Growth (CGC.US) rose by more than 23% [1] - SNDL (SNDL.US) increased by over 19% [1] - Aurora Cannabis (ACB.US) experienced a rise of over 11% [1] - Cronos Group (CRON.US) gained over 5% [1] Group 2 - Reports indicate that President Trump is expected to push for the reclassification of cannabis as a "lower risk drug" [1] - Trump is considering moving cannabis from Schedule I, which indicates no medical use and high abuse potential, to Schedule III, which includes substances with lower dependency and addiction potential [1]
大麻股集体狂飙 Tilray Brands(TLRY.US)大涨超32%